Summary A study was made of the relatonship between the intrinsic radiosensifivity of human cervical tumours and the expression of the DNA repair enzyme human apurnic/apyrmidinic endonuclease (HAP1). The radiosensitivity of clonogenic cells in tumour biopsies was measured as surviving fraction at 2 Gy (SF2) using a soft agar assay. HAP1 expression levels were determined after staining of formalin-fixed paraffin-embedded tumour sections with a rabbit antiserum raised against recombinant HAP1. Both measurements were obtained on pretreatment biopsy material. All 25 tumours examined showed positive staining for HAP1, but there was heterogeneity in the level of expression both within and between tumours. The average coefficients of variation for intra-and intertumour heterogeneity were 620o and 82% respectively. There was a moderate but significant positive correlation between the levels of HAP1 expression and SF2 (r= 0.60, P = 0.002). Hence, this study shows that there is some relationship between intrinsic radiosensitivity and expression of a DNA repair enzyme in cervical carcinomas. The resutts suggest that this type of approach may be useful in the development of rapid predictive tests of tumour radiosensitivity.
There is considerable interest in increasing the understanding of the factors that determine the radiosensitivitv of cells from different individuals (West. 1995) . Exentuallv. these factors may be exploited in the development of rapid assays for predicting the radioresponsiveness of both normal and malignant cells. It has been estimated that the theoretical benefits of radiosensitivitx testin, could be substantial in terms of improxing outcome and reducing morbidity for cancer patients undergoing radiotherapy (MacKay et al. 1998) .
The survixal of cells follow ing exposure to radiation is governed by complex interactions between a large number of proteins inxolhed in DNA damage recognition. DNA repair and the response of the cells to unrepaired or misrepaired DNA damage. For example. absence of components of the DNA doublestrand break recognition complex DNA-PK has been identified as a cause of radiosensitivitv in the hamster xrs6 line (lackinc the Ku8O protein : Taccioli et al. 1994) and in the scid mouse (lacking the p350 protein: Petersen et al. 1995). It is. therefore. reasonable to suggest that variations in the lexels of expression of such proteins may result in subtle variations in radiosensitivity.
The major lethal DNA lesion produced by ionizing radiation is considered to be the double-strand break. possibly associated x%ith other tvpes of end-structure damage at the break-to constitute .clustered' damage (Ward. 1994 Apnl 1998 Correspondence to C West apynmidinic (API sites generated either du 'nn initial chemical reactions after irradiation or as a result of the processing of base lesions by components of the base excision repair path%vay see Demple and Harrison. 1994 ). This latter pathvvay involves the recognition of damage by a DNA repair gly cosylase to produce AP sites. which are subsequentlx incised by an AP Ivase or AP endonuclease. The HAP1 (also known as APEI and APEX in the mouse) protein is considered to be the major AP endonuclease in human cells and has homology of structure and function to Eschenrchia coli exonuclease III. which has been shown to play an important role in DNA repair and response to ionizinc, radiation (Cunningham et al. 1986 ). The HAP1 protein is identical to the redox factor 1 protein (ref1). which has been show-n to be involved in the redox regulation of DNA bindinc of transcription factors such as c-fos and c-jun (Xanthoudakis and Curran. 1992) .
Chen et al (1992) reported that two radiosensitive mouse lymphoblastoid lines show~ved very lo%v expression levels of APEX as deternmined bx Western analvsis and that their radiosensitivity w as reduced by transfection wvith a plasmid encoding HAP 1. Furthermore. in data reported by Ono et al (1995) . there was a trend towards an association betw-een HAP 1 actix ity and the radiosensitivities of six human galioma cell lines.
The present study was caried out to examine the expression of HAP1 in a series of human cernical carcinomas that had previously been assayed for radiosensitivity using a clonogenic assay (West et al. 1997) . The aim was to establish any relationship between the two measurements. and so determiine the importance of HAP1 expression in the radiosensitivity of primary cen-ical carcinoma. The membrane was wetted with PBS containing 0.3%c (PBST) and membrane-bound proteins stained with 0.11% black India ink in PBST for approximately 30 min with agitation. Excess ink was removed by washing with PBST for 30 min. and the membrane incubated in TBST blocking buffer (5%c non-fat milk in 50 mM1 Tris-HCl pH 7.5. 150 mv-sodium chlonrde. 0.1%7 v/x Tween 20) for 1 h at room temperature. The membrane was incubated with the primarv antiserum (anti-HAPI at 1:666 dilution) in blocking buffer for 1.5 h at room temperature. Unbound antibody was removed by washing three times in TBST. The secondary antibody was then applied: goat-anti-rabbit IgG conjugated with horseradish peroxidase (Dako). at a 1:2000 dilution in blocking buffer. for 1 h at room temperature. After three more washes in TBST. bound antibody was detected using a luminol-based chemiluminescence method (ECL. Amersham).
Immunohistochemistry of HAP1 Formalin-fixed. paraffin-embedded sections (5 jm thick) were dewaxed in xylene for 10 min and rehydrated by passage through a graded ethanol series to tap water. The sections were then treated to unmask antigens bv microwaving in 11 of 10 nmi citrate buffer (pH 6.0) for 25 min at 700 W. After cooling for 10 nmmn in the buffer. the sections were cooled to room temperature by the addition of tap water and immersed in Tris-buffered saline (TBS).
Endogenous peroxidases were blocked with 3%7c hydrogen peroxide in TBS for 20 mimn and the sections washed twice for 5 min in TBS. The sections were then blocked further using 10%7 
Immunohistochemistry of p53
Tumour sections were treated as described for HAP1 staining but the anti-p53 polyclonal antibody D07 (Novocastra) was used at a concentration of 1:50 and TBS was used as the negative control. Expression was assessed in 1000 tmou cells in ten fields of 100 cells per field to obtain the percentages of positively stained cells. Values were expressed as means and standard errors of the ten fields.
Tumour radiosensitvity
The patient details, treatment protocols and assay method have been described in detail elsewhere (West et al, 1997) . The study was performed following South Manchester Medical Research Ethics Committee approval and only women with stage I-EI proven carcinoma of the cervix who gave informed consent were included in the study. Tumour specimens were received immediately before the commencement of radiotherapy. Samples were disaggregated using an enzyme cocktail containing 0.4 mg ml-' DNAase, and 0.5 mg ml-pronase and collagenase. Suspensions were cultured using a soft agar clonogenic assay in Ham's F12 medium supplemented with 15% fetal calf serum, August rat red blood cells, 10 ng mln-epidermal growth factor, 10 ig ml insulin, 0.5 jig ml-l hydrocortisone and 2.5 gg ml-transferrin. 
Data analysis
Relationships between quantitative variables were obtained by using Pearson parametric correlations. A paired t-test was used to determine statistical differences between datasets, and a significance level of 0.05 was used throughout.
RESULTS
Tlhe anti-HAPl antiserum produced was specific for a single 38-kDa protein in human cells. Figure 1 illustrates this finding using two human tumour cell lines (A2780, K562). No cross-reaction was observed in rodent cells expressing high levels of AP-endonuclease (CHO, a rat prostate line), nor against the E. coli structural homologue exonuclease JI (Figure 1 ). When used against paraffin sections, all of the 25 cervical carcinomas examined show some degree of HAP1 expression in both tumour and stromal tissue. No non-specific staining was seen on any of the sections trated with preimmune serum (not shown). The specificity of the antibody was demonstated by preadsorbing the antiserum with gel purified rHAPl before staining one tumour section ( Figure 2B ). Only minimal and uniform staining of the entire section was observed after this treatment indicating that the antiserum was specific for HAP1 under the conditions used. The nuclear pattem of HAPI staining varied between tumours, with some displaying an intense and relatively uniform pattem whereas others demonstrated a reticulate pattem. There was also a marked heterogeneity in staining intensity between different tumours (Figure 2A . C and D) and between nuclei within the same tumour tissue. The staining was carried out in two batches with four tumours stained in both runs. For these four tumours, there was good agreement of the staining intensity between the different staining runs.
Only strongly stained tumour cells were scored as positive. A list of the levels of HAPIl-positive cells is given in Table I Radiosensitivity. measured as surviving fraction at 2 Gy (SF,).
was obtained as part of previous studies (West et al. 1997 ). Increasing HAP expression correlated significantly with decreasing intrinsic radiosensitivity. Figure 4 illustrates the data obtained by one scorer but similar results were obtained by the other scorer (r = 0.40. P = 0.046).
The clinical characteristics of the patients are listed in Table 1 . All patients were treated with radical radiotherapy alone. There were no significant relationships between the level of HAP 1 expression and any of the clinical characteristics. Of the 25 patients studied. 17 were alive and well. and eicht had died of cancer. The means (and standard errors) of HAPI levels for these (Chen et al. 1992 ). Also. although not statistically significant. a somewhat more extensive study on six human alioma cell lines suggested a positive I * association between HAP1 expression and radiosensitivity (Ono et al. 1995) . In this context. it should be noted that the levels of HAP1 in primary cells have been reported to be much lower than those in immortal cell lines (La-Belle and Lin. 1984: Chen et al. 1991) . so that observations using primary material are probably more relevant increased radiosensitivity in cell lines (Walker et al. 1994 (Ward. 1994 ).
This has been further refined to double-strand breaks persisting at ps were 35±7%7 and 45±12%cc respectively. Although a specified period after exposure (Wurm et al. 1994) . and recent pression tended to be lower in the alive and well group.
reports further suggest that. in addition. detection of misrepaired ence did not reach statistical significance (P = 0.31 ) lesions may increase the accuracy of prediction of cellular Wel of p53 expression was examined in 16 of the tumours radiosensitivity (Dahm-Daphi and Dikomey. 1996) . Because it ata are aiven in Table 1 . A comparison was made of the blocks DNA polymerase and DNA ligase. it is reasonable to IAPI expression in the five tumours with no mutant p53 sugest that 3'-terminal damage could. w-here HAP1 levels are n with the 11 tumours with some expression. The mean limiting. be responsible for the cell's inability to repair double-HAP1 positive cells for the two groups were 12c and strand breaks. and that such lesions may be the basis of some ectively. There was a significantly higher level of HAP1 misrepair as a consequence of the attempts of the cellular repair n in p53 positive tumours (P = 0.02). machinerv to circumvent the lesion.
It is also possible that the effect of HAP1 expression on cellular SSION radiosensitivity may be related to its other functions. The latter are the redox control of transcription factor (AP-1 binding to DNA work has demonstrated that DNA repair mutants that are (Xanthoudakis and Curran. 1992 ) and the redox-dependent and [y lacking in specific repair functions can be radiosensitive -independent stimulation of p53 (Jayaraman et al. 1997 the tumours studied, data were available on the expression of mutant p53 protein. In tumours with no mutant p53 expression, there were significantly lower levels of HAPI compared with tumours with some expression. Although the tumour numbers are small, the last observation may be related to the finding, described above, of HAPI stimulation of wildtype p53 protein. Transfection studies using HAP1 cDNA mutated in the redox or repair domains would help to address this question.
Irrespective of the basis of the relationship between the in situ levels of expression of HAPI and SF,, the present findings may have important clinical implications. Measurements of tumour radiosensitivity have been shown to be prognostic for outcome following radiotherapy (West et al, 1997) . However, the clonogenic determination of SF, is both time consuming and labour intensive, and so there is a need to develop a rapid predictive assay for tumour radiosensitivity. Our results indicate that, at least for cervical carcinoma, quantitation of the expression of HAP1 and probably other repair enzymes relevant to ionizing radiation damage may be useful.
